Question 1

What are the specific benefits of participating in this trial compared to standard treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the side effects of the shorter hormone therapy be monitored?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the chances that I will be assigned to the shorter treatment group?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my overall health and quality of life be assessed during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I still receive standard treatment if I choose not to participate in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Reduced Length of ADT and ARTA With XRT in High-Risk Prostate Cancer (RELAX): A Randomised Trial clinical trial (NCT06818682). Contact the study team or your healthcare provider for specific answers.

What this study is about